Summary:
Bidding For The Purchase Of Rivaroxaban 20 Mg Film-Coated Tablet By Electronic Bidding (E-Bidding) Country:
Thailand Estimated Cost:
THB 1131180 Notice Type:
Contract Award Deadline:
Posting Date:
16 Aug 2024 |
Summary:
Bidding For The Purchase Of Rivaroxaban 15 Mg Film-Coated Tablet By Electronic Bidding (E-Bidding) Country:
Thailand Estimated Cost:
THB 625575 Notice Type:
Contract Award Deadline:
Posting Date:
16 Aug 2024 |
Summary:
Np35924B Rivaroxaban Tablets Country:
United Kingdom Estimated Cost:
GBP 81156 Notice Type:
Contract Award Deadline:
Posting Date:
02 Aug 2024 |
Summary:
* Electronic Bidding * - Price Registration For The Supply Of Legal Action Medicines: Cilostazole 100Mg, Desvenlafazine 100Mg, Desvenlafaxine, 50Mg, Ribociclib, Rivaroxaban 10Mg, Triexyphenidil, Rosuvastatin, Methotrexate 25Mg/Ml - Cilostazol, 1 00 Mg. Box With 60 Cebralat Tablets. Desvenlafaxine Succinate Monohydrate 100 Mg In Coated Extended-Release Tablet Imense. Desvenlafaxine Succinate Monohydrate 50 Mg In Elifore Controlled-Release Coated Tablet. Ribocycl * Country:
Brazil
Notice Type:
Contract Award Deadline:
Posting Date:
29 Jun 2024 |
Summary:
* Electronic Bidding * - Price Registration For The Supply Of Legal Action Medicines: Cilostazole 100Mg, Desvenlafazine 100Mg, Desvenlafaxine, 50Mg, Ribociclib, Rivaroxaban 10Mg, Triexyphenidil, Rosuvastatin, Methotrexate 25Mg/Ml - Cilostazol, 1 00 Mg. Box With 60 Cebralat Tablets. Desvenlafaxine Succinate Monohydrate 100 Mg In Coated Extended-Release Tablet Imense. Desvenlafaxine Succinate Monohydrate 50 Mg In Elifore Controlled-Release Coated Tablet. Ribocicl * Country:
Brazil
Notice Type:
Contract Award Deadline:
Posting Date:
27 Jun 2024 |
Summary:
Tender For Purchase Of Rivaroxaban 20 Mg Film-Coated Tablet By Electronic Bidding Method. Country:
Thailand Estimated Cost:
THB 2889000 Notice Type:
Procurement Plan Deadline:
17 Jun 2025 Posting Date:
18 Jun 2024 |
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form) Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Apr 2026 Posting Date:
22 May 2024 |
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - In All Potencies Except 2.5 Mg Per Divided Oral Dosage Form) Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Apr 2026 Posting Date:
22 May 2024 |
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form) Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Apr 2026 Posting Date:
22 May 2024 |
Summary:
Medicines With The Active Ingredient Rivaroxaban (Atc: B01Af01 - With A Potency Of 2.5 Mg Per Divided Oral Dosage Form) Country:
Germany
Notice Type:
Tender Notice Deadline:
30 Apr 2026 Posting Date:
22 May 2024 |
Rivaroxaban Tenders and Contracts
Rivaroxaban tenders contracts bids and business opportunities -